Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1983 3
1985 1
1988 1
1992 2
1994 2
1995 1
1996 1
1997 1
2000 2
2003 2
2008 3
2009 2
2010 1
2011 1
2012 1
2013 2
2014 2
2015 1
2016 6
2017 6
2018 4
2019 4
2021 3
2022 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
[Articular diseases and uveitis].
Benítez Del Castillo JM, Díaz-Valle D, Pato E, López-Abad C, Alejandre N. Benítez Del Castillo JM, et al. Among authors: pato e. An Sist Sanit Navar. 2008;31 Suppl 3:83-95. An Sist Sanit Navar. 2008. PMID: 19169297 Free article. Review. Spanish.
Efficacy of Anti-IL6-Receptor Tocilizumab in Refractory Cystoid Macular Edema of Birdshot Retinochoroidopathy Report of Two Cases and Literature Review.
Calvo-Río V, Blanco R, Santos-Gómez M, Díaz-Valle D, Pato E, Loricera J, González-Vela MC, Demetrio-Pablo R, Hernández JL, González-Gay MA. Calvo-Río V, et al. Among authors: pato e. Ocul Immunol Inflamm. 2017 Oct;25(5):604-609. doi: 10.1080/09273948.2016.1231331. Epub 2016 Oct 11. Ocul Immunol Inflamm. 2017. PMID: 27726475 Review.
Inflammatory Relapses after Immunosuppressive Drug Discontinuation in Uveitis Patients: A Survival Analysis.
Gómez-Gómez A, García-González J, Peiteado D, Borrego-Sanz L, Arriola-Villalobos P, Esteban-Ortega M, Martín-López M, Ventura-Hidalgo M, Perez-Blazquez E, Pato E, Díaz-Valle D, Muñoz-Fernández S, Rodriguez-Rodriguez L. Gómez-Gómez A, et al. Among authors: pato e. Ocul Immunol Inflamm. 2021 Feb 17;29(2):376-387. doi: 10.1080/09273948.2019.1681469. Epub 2019 Nov 11. Ocul Immunol Inflamm. 2021. PMID: 31710514
Clinical and Pathological Predictors of Death for Adrenocortical Carcinoma.
Pato E, Srougi V, Zerbini C, Ledesma FL, Tanno F, Almeida MQ, Nahas W, Latronico AC, Mendonca BB, Chambô JL, Fragoso MCBV. Pato E, et al. J Endocr Soc. 2024 Jan 8;8(4):bvad170. doi: 10.1210/jendso/bvad170. eCollection 2024 Feb 19. J Endocr Soc. 2024. PMID: 38384443 Free PMC article.
Efficacy, safety and cost-effectiveness of methotrexate, adalimumab or their combination in non-infectious non-anterior uveitis: a protocol for a multicentre, randomised, parallel three arms, active-controlled, phase III open label with blinded outcome assessment study.
Rivas AB, Lopez-Picado A, Calamia V, Carreño E, Cocho L, Cordero-Coma M, Fonollosa A, Francisco Hernandez FM, Garcia-Aparicio A, Garcia-Gonzalez J, Mondejar JJ, Lojo-Oliveira L, Martínez-Costa L, Munoz S, Peiteado D, Pinto JA, Rodriguez-Lozano B, Pato E, Diaz-Valle D, Molina E, Tebar LA, Rodriguez-Rodriguez L; CoTHEIA Study Group. Rivas AB, et al. Among authors: pato e. BMJ Open. 2022 Mar 22;12(3):e051378. doi: 10.1136/bmjopen-2021-051378. BMJ Open. 2022. PMID: 35318229 Free PMC article.
Predictors of health-related quality of life in musculoskeletal disease patients: a longitudinal analysis.
Madrid-García A, León-Mateos L, Pato E, Jover JA, Fernández-Gutiérrez B, Abasolo L, Menasalvas E, Rodríguez-Rodríguez L. Madrid-García A, et al. Among authors: pato e. Ther Adv Musculoskelet Dis. 2021 Jul 25;13:1759720X211034063. doi: 10.1177/1759720X211034063. eCollection 2021. Ther Adv Musculoskelet Dis. 2021. PMID: 34367344 Free PMC article.
Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease.
Martín-Varillas JL, Calvo-Río V, Beltrán E, Sánchez-Bursón J, Mesquida M, Adán A, Hernandez MV, Garfella MH, Pascual EV, Martínez-Costa L, Sellas-Fernández A, Cordero-Coma M, Díaz-Llopis M, Gallego R, Salom D, Ortego N, García-Serrano JL, Callejas-Rubio JL, Herreras JM, García-Aparicio Á, Maíz O, Blanco A, Torre I, Díaz-Valle D, Pato E, Aurrecoechea E, Caracuel MA, Gamero F, Minguez E, Carrasco-Cubero C, Olive A, Vázquez J, Ruiz-Moreno O, Manero J, Muñoz-Fernández S, Martinez MG, Rubio-Romero E, Toyos-Sáenz de Miera FJ, López Longo FJ, Nolla JM, Revenga M, González-Vela C, Loricera J, Atienza-Mateo B, Demetrio-Pablo R, Hernández JL, González-Gay MA, Blanco R. Martín-Varillas JL, et al. Among authors: pato e. Ophthalmology. 2018 Sep;125(9):1444-1451. doi: 10.1016/j.ophtha.2018.02.020. Epub 2018 Mar 27. Ophthalmology. 2018. PMID: 29602570 Free article. Clinical Trial.
Long-term use of antimalarial drugs in rheumatic diseases.
Jover JA, Leon L, Pato E, Loza E, Rosales Z, Matias MA, Mendez-Fernandez R, Díaz-Valle D, Benitez-Del-Castillo JM, Abasolo L. Jover JA, et al. Among authors: pato e. Clin Exp Rheumatol. 2012 May-Jun;30(3):380-7. Epub 2012 Jun 26. Clin Exp Rheumatol. 2012. PMID: 22339928
48 results